Sign In
Buy CUE
$26.84
-3.56 (-11.71%)
At Close: Jul 31, 2026
Cue Biopharma (NASDAQ:CUE) Upgraded by BidaskClub to "Strong-Buy"
10:06am, Saturday, 25'th Apr 2020
Cue Biopharma (NASDAQ:CUE) was upgraded by equities research analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a research note issued to investors on Saturday, BidAskClub
The Zacks Analyst Blog Highlights: Cue Biopharma, PJT Partners, Avenue Therapeutics, SpartanNash and Gaia
03:07pm, Friday, 24'th Apr 2020
The Zacks Analyst Blog Highlights: Cue Biopharma, PJT Partners, Avenue Therapeutics, SpartanNash and Gaia
The Zacks Analyst Blog Highlights: Cue Biopharma, PJT Partners, Avenue Therapeutics, SpartanNash and Gaia
03:07pm, Friday, 24'th Apr 2020
The Zacks Analyst Blog Highlights: Cue Biopharma, PJT Partners, Avenue Therapeutics, SpartanNash and Gaia
3 Monster Growth Stocks Gearing up for Gains
02:50pm, Friday, 24'th Apr 2020
Just when it looked like time to throw in the towel, the market pulled through and delivered a win. Stabilizing crude oil prices, a few better-than-expected earnings reports as well as the possibility
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks hitting 52-week highs April 23.) * Arcturus Therapeutics Ltd (NASDAQ: ARCT) * Chemb
5 Stocks With Recent Price Strength to Tap Market Rally
11:50am, Friday, 24'th Apr 2020
Investors target stocks that are witnessing a bullish run. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.
Stocks That Hit 52-Week Highs On Thursday
02:41pm, Thursday, 23'rd Apr 2020
During Thursday's morning trading, these companies set new 52-week highs.Noteworthy Points: * Johnson & Johnson (NYSE: JNJ) was the largest company by market cap to set a new 52-week high. * The sm
Stocks Recover About 2% After Oil Stabilizes
01:15pm, Thursday, 23'rd Apr 2020
Stocks Recover About 2% After Oil Stabilizes
The Daily Biotech Pulse: FDA Nod For Immunomedics, Lilly's Solid Q1 Beat, Predictive Oncology Restructures Debt
11:53am, Thursday, 23'rd Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks htitting 52-week highs April 22.) * Dr.Reddy's Laboratories Ltd (NYSE: RDY) * Johns
5 Top Small-Cap Stocks Braving Coronavirus Bloodbath
11:25am, Thursday, 23'rd Apr 2020
A handful of small-cap stocks have skyrocketed defying the coronavirus-induced market mayhem and extreme volatility.
5 Top Small-Cap Stocks Braving Coronavirus Bloodbath
11:25am, Thursday, 23'rd Apr 2020
A handful of small-cap stocks have skyrocketed defying the coronavirus-induced market mayhem and extreme volatility.
Cue Biopharma price target raised to $25 from $21 at Stifel CUE
11:58am, Tuesday, 21'st Apr 2020
Cue Biopharma price target raised to $25 from $21 at Stifel Stifel CUE
Cue Biopharma, Merck enter into clinical trial collaboration agreement CUE;MRK
12:37pm, Monday, 20'th Apr 2020
Cue Biopharma, Merck enter into clinical trial collaboration agreement CUE MRK
Cue Biopharma, Inc. (CUE), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells within the body, announced t
Cronos Financials 'Restatement', And Other News: The Good, Bad And Ugly Of Biopharma
04:24pm, Friday, 20'th Mar 2020
Cronos said it will need to restate parts of its financial statements. Biohaven's migraine drug gets fast tracked. Cue biopharma's earnings.
